Prepuberal stress and obesity: effects on serum corticosterone, prolactin, testosterone and precancerous prostate lesions in adult rats
DOI:
https://doi.org/10.32471/exp-oncology.2312-8852.vol-41-no-2.13093Keywords:
cancer, lipopolysaccharide, obesity, prostate, puberty, stressAbstract
Summary. Stress during puberty and obesity can represent conditions that facilitate the long-term development of diseases, especially for stress-related disorders that depend on neuroendocrine and immune responses. The prostate is prone to diseases that result from neuroendocrine or immune challenges, such as cancer. Aim: In the present study, we assessed the long-term effects of an acute pubertal stressor (immune-challenge) or obesity on the development of precancerous lesions in rats. Materials and Methods: Pubertal male rats received a single injection of lipopolysaccharide (LPS) or saline during puberty (5 weeks of age). In adulthood (8 weeks old), subgroups of males were fed with hypercaloric liquid diet to induce obesity. This resulted in a total of six subgroups: (1) intact-non obese, (2) intact-obese, (3) saline-non obese, (4) saline-obese, (5) LPS-non obese, and (6) LPS-obese. At 16 weeks of age the rats were sacrified for prostate histology (hematoxylin and eosin stain) and hormone analysis (testosterone, corticosterone and prolactin). Results: As compared to intact-non obese rats, males treated with LPS and those with obesity expressed histological alterations in both the dorsolateral and ventral portions of the prostate. Only prolactin was altered in LPS-treated males, whereas corticosterone was altered in LPS-obese rats. Conclusions: These results indicate that puberal exposure to an immune challenge or obesity facilitate the development of prostatic lesions in adult male rats. We discuss the role of hormones in the development of precancerous lesions.
References
Aalberts M, Stout TA, Stoorvogel W. Prostasomes: extracellular vesicles from the prostate. Reproduction 2014; 147: 1–14.
Kravets FG, Lee J, Singh B, et al. Prostasomes: current concepts. Prostate 2000; 43: 169–74.
Shafik A, Shafik AA, El Sibai O, et al. Contractile activity of the prostate at ejaculation: an electrophysiologic study. Urology 2006; 67: 793–6.
Sfanos KS, De Marzo AM. Prostate cancer and inflammation: the evidence. Histopathology 2012; 60: 199–215.
Agoulnik IU, Krause WC, Bingman WE, 3-rd, et al. Repressors of androgen and progesterone receptor action. J Biol Chem 2003; 278: 31136–48.
Noble RL. Sex steroids as a cause of adenocarcinoma of the dorsal prostate in Nb rats, and their influence on the growth of transplants. Oncology 1977; 34: 138–41.
Herrera-Covarrubias D, Coria-Avila GA, Chavarria-Xicotencatl P, et al. Long-term administration of prolactin or testosterone induced similar precancerous prostate lesions in rats. Exp Oncol 2015; 37: 13–8.
Mearini L, Zucchi A, Nunzi E, et al. Low serum testosterone levels are predictive of prostate cancer. World J Urol 2013; 31: 247–52.
Fernandez I, Touraine P, Goffin V. Prolactin and human tumourogenesis. J Neuroendocrinol 2010; 22: 771–7.
Williams TH. Occult carcinoma and benign hypertrophy of the prostate in men over fifty years of age. Treat Serv Bull 1954; 9: 201–16.
Allott EH, Howard LE, Song HJ, et al. Racial differences in adipose tissue distribution and risk of aggressive prostate cancer among men undergoing radiation therapy. Cancer Epidemiol Biomarkers Prev 2014; 23: 2404–12.
Roman MD, Niclis C, Tumas N, et al. Tobacco smoking patterns and differential food effects on prostate and breast cancers among smokers and nonsmokers in Cordoba, Argentina. Eur J Cancer Prev 2014; 23: 310–8.
Chang SN, Han J, Abdelkader TS, et al. High animal fat intake enhances prostate cancer progression and reduces glutathione peroxidase 3 expression in early stages of TRAMP mice. Prostate 2014; 74: 1266–77.
Haque R, Van Den Eeden SK, Wallner LP, et al. Association of body mass index and prostate cancer mortality. Obes Res Clin Pract 2014; 8: 374–81.
Herrera-Covarrubias D, Coria-Avila G, Hernandez ME, et al. Stress during puberty facilitates precancerous prostate lesions in adult rats. Exp Oncol 2017; 39: 269–75.
Perez-Hernandez AI, Catalan V, Gomez-Ambrosi J, et al. Mechanisms linking excess adiposity and carcinogenesis promotion. Front Endocrinol (Lausanne) 2014; 5: 65.
Kirschner MA, Ertel N, Schneider G. Obesity, hormones, and cancer. Cancer Res 1981; 41: 3711–7.
Caprio S, Tamborlane WV, Silver D, et al. Hyperleptinemia: an early sign of juvenile obesity. Relations to body fat depots and insulin concentrations. Am J Physiol 1996; 271: 626–30.
Herrera-Covarrubias D, Coria-Avila GA, Fernandez-Pomares C, et al. Obesity as a risk factor in the development of cancer. Rev Peru Med Exp Salud Publica 2015; 32: 766–76 (in Spanish).
Flores IE, Sierra-Fonseca JA, Davalos O, et al. Stress alters the expression of cancer-related genes in the prostate. BMC Cancer 2017; 17: 621.
Laugero KD, Moberg GP. Effects of acute behavioral stress and LPS-induced cytokine release on growth and energetics in mice. Physiol Behav 2000; 68: 415–22.
Kentner AC, McLeod SA, Field EF, et al. Sex-dependent effects of neonatal inflammation on adult inflammatory markers and behavior. Endocrinology 2010; 151: 2689–99.
Cai KC, van Mil S, Murray E, et al. Age and sex differences in immune response following LPS treatment in mice. Brain Behav Immun 2016; 58: 327–37.
Laroche J, Gasbarro L, Herman JP, et al. Enduring influences of peripubertal/adolescent stressors on behavioral response to estradiol and progesterone in adult female mice. Endocrinology 2009; 150: 3717–25.
Herrera-Covarrubias D, Tecamachaltzi-Silvaran MB, Barradas-Moctezuma M, et al. Effect of copulation on potentially precancerous prostate lesions, serum testosterone and prolactin levels in rats. Exp Oncol 2016; 38: 73–9.
McCormick CM, Mathews IZ, Thomas C, et al. Investigations of HPA function and the enduring consequences of stressors in adolescence in animal models. Brain Cogn 2010; 72: 73–85.
Romeo RD, Bellani R, Karatsoreos IN, et al. Stress history and pubertal development interact to shape hypothalamic-pituitary-adrenal axis plasticity. Endocrinology 2006; 147: 1664–74.
Grossmann ME, Huang H, Tindall DJ. Androgen receptor signaling in androgen-refractory prostate cancer. J Natl Cancer Inst 2001; 93: 1687–97.
Pertschuk LP, Zava DT, Gaetjens E, et al. Detection of androgen and estrogen receptors in human prostatic carcinoma and hyperplasia by fluorescence microscopy. Res Commun Chem Pathol Pharmacol 1978; 22: 427–30.
Webber M. Polypeptide hormones and the prostate. In: The prostate cell: structure and function. Murphy GP, Sandberg AA, Karr JP, eds. Alan R. Liss: New York, 1981.
Harper ME, Peeling WB, Cowley T, et al. Plasma steroids. Acta Endocrinol (Copenh) 1976; 81: 409–26.
Saroff J, Kirdoni RY, Chu TM, et al. Measurements of prolactin and androgens in patients with prostatic disease. Oncology 1980; 37: 46–52.
Freeman ME, Kanyicska B, Lerant A, et al. Prolactin: structure, function, and regulation of secretion. Physiol Rev 2000; 80: 1523–631.
Sinha YN, Salocks CB, Vanderlaan WP. Control of prolactin and growth hormone secretion in mice by obesity. Endocrinology 1976; 99: 881–6.
Brede CM, Shoskes DA. The etiology and management of acute prostatitis. Nat Rev Urol 2011; 8: 207–12.
Cai T, Mazzoli S, Meacci F, et al. Epidemiological features and resistance pattern in uropathogens isolated from chronic bacterial prostatitis. J Microbiol 2011; 49: 448–54.
Boehm BJ, Colopy SA, Jerde TJ, et al. Acute bacterial inflammation of the mouse prostate. Prostate 2012; 72: 307–17.
Elkahwaji JE, Hauke RJ, Brawner CM. Chronic bacterial inflammation induces prostatic intraepithelial neoplasia in mouse prostate. Br J Cancer 2009; 101: 1740–8.
Hackett RA, Hamer M, Endrighi R, et al. Loneliness and stress-related inflammatory and neuroendocrine responses in older men and women. Psychoneuroendocrinology 2012; 37: 1801–9.
Bierhaus A, Wolf J, Andrassy M, et al. A mechanism converting psychosocial stress into mononuclear cell activation. Proc Natl Acad Sci U S A 2003; 100: 1920–5.
Afrasiabi K, Zhou YH, Fleischman A. Chronic inflammation: is it the driver or is it paving the road for malignant transformation? Genes Cancer 2015; 6: 214–9.
Dennis LK, Lynch CF, Torner JC. Epidemiologic association between prostatitis and prostate cancer. Urology 2002; 60: 78–83.
Sarma AV, McLaughlin JC, Wallner LP, et al. Sexual behavior, sexually transmitted diseases and prostatitis: the risk of prostate cancer in black men. J Urol 2006; 176: 1108–13.
Sutcliffe S, Giovannucci E, De Marzo AM, et al. Gonorrhea, syphilis, clinical prostatitis, and the risk of prostate cancer. Cancer Epidemiol Biomarkers Prev 2006; 15: 2160–6.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Experimental Oncology
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
